Commercialization of an Advanced Technology for T Cell Receptor Analysis and Engineering

T 细胞受体分析和工程先进技术的商业化

• 批准号: 9193662
• 负责人: David Scott Johnson
• 金额: $ 4万
• 依托单位: GIGAGEN, INC.
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-03-11 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9193662
• 关键词: Antibodies; Antigens; Area; Autoimmune Diseases; Biological Markers; CLIA certified; Capital; Cataloging; Catalogs; Cell Line; Cell Separation; Cell physiology; Cells; Chemistry; Clinical; Communicable Diseases; DNA Sequence; Detection; Devices; Diagnostic; Disease; Doctor of Philosophy; Elements; Engineering; FOXP3 gene; Fluorescence-Activated Cell Sorting; Genes; Genomics; Genotype; Goals; Graft Rejection; Hour; Human; Hypersensitivity; Immune; Immune system; Immunologist; Immunology; Interferon Type II; Interleukin-10; Interleukin-17; Interleukin-2; Legal patent; Malignant Neoplasms; Market Research; Marketing; Measures; Methods; Microfluidics; Modeling; Monitor; Phase; Phenotype; Population; Reagent; Receiver Operating Characteristics; Regulatory T-Lymphocyte; Sampling; Scientist; Sensitivity and Specificity; Sequoia; Small Business Innovation Research Grant; Specialist; T cell therapy; T-Cell Receptor; T-Lymphocyte; TNF gene; Technology; Technology Transfer; Testing; Time; United States National Institutes of Health; Variant; Work; antibody conjugate; base; blind; clinically relevant; commercialization; cytokine; deep sequencing; fluorophore; improved; interest; new technology; prevent; product development; research study; tool; transcriptome sequencing; validation studies

 DESCRIPTION (provided by applicant): An Advanced Tool for T Cell Analysis Using Microfluidics Organization: GigaGen Inc. PI: David S. Johnson, Ph.D. Better methods for discovery and monitoring of immune system biomarkers could improve treatment of a variety of diseases and conditions, including cancer, autoimmune diseases, allergies, transplant rejection, and infectious diseases. We are building a novel technology that uses microfluidics and DNA sequencing to understand the immune system in unprecedented ways.

 描述（由申请人提供）：使用微流体技术进行T细胞分析的先进工具组织：GigaGen Inc. PI：大卫S.约翰逊博士发现和监测免疫系统生物标志物的更好方法可以改善各种疾病和病症的治疗，包括癌症，自身免疫性疾病，过敏，移植排斥和传染病。我们正在开发一种新技术，利用微流体和DNA测序以前所未有的方式了解免疫系统。